CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ali,Hazrati

第一单位： Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

作者： Ali,Hazrati ^[1] ; Kosar,Malekpour ^[2] ; Sara,Soudi ^[3] ; Seyed Mahmoud,Hashemi ^[4]

作者单位： Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. ^[1] Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. ^[2] Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: soudi@modares.ac.ir. ^[3] Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: smmhashemi@sbmu.ac.ir. ^[4]

关键词 Cell therapy Crispr/Cas9 Cytokines Extracellular vesicles MSCs Regenerative medicine

主题词间质干细胞(Mesenchymal Stem Cells)

DOI 10.1016/j.biopha.2022.113943

PMID 36411629

发布时间 2022-11-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2022年156卷

113943页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相似文献

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相似文献

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相关期刊

检索历史清除